Please assess the completion status of the following clinical trial:

Trial Title: Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients~* 2-16 years old~* diagnosed with Atopic Dermatitis according to Hanifin and Rajka criteria~Exclusion Criteria:~* patients with serious skin disorder other than Atopic Dermatitis~* patients taking systemic corticosteroids or anti-inflammatory medications.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Tacrolimus group (Type: ACTIVE_COMPARATOR): 100 patients treated by thin layer of 0.03% topical tacrolimus ointment on the affected areas twice daily for 4 months.
- Hydrocortisone group (Type: ACTIVE_COMPARATOR): 100 patients treated by thin layer of 1% hydrocortisone cream on the affected areas twice daily for 4 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).